{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:08Z","timestamp":1786984208707,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022850","name":"Myovant Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ajog.2023.10.030","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:21:09Z","timestamp":1697628069000},"page":"237.e1-237.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relugolix combination therapy in Black\/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study"],"prefix":"10.1016","volume":"230","author":[{"given":"Elizabeth A.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Lukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Sandra","family":"Madueke-Laveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Proehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Schulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica E.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.10.030_bib1","first-page":"16","article-title":"Uterine fibroids: hiding in plain sight","volume":"37","author":"Stewart","year":"2022","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ajog.2023.10.030_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2023.10.030_bib3","first-page":"287","article-title":"Burden of uterine fibroids: an African perspective, a call for action and opportunity for intervention","volume":"2","author":"Igboeli","year":"2019","journal-title":"Curr Opin Gynecol Obstet"},{"key":"10.1016\/j.ajog.2023.10.030_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2023.10.030_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2023.10.030_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","article-title":"Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. Women","volume":"27","author":"Marsh","year":"2018","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2023.10.030_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2023.10.030_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2023.10.030_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2023.10.030_bib13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.030_bib14","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib15","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas: ACOG Practice Bulletin, Number 228","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.fertnstert.2020.02.110","article-title":"Myomectomy associated blood transfusion risk and morbidity after surgery","volume":"114","author":"Kim","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.030_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.030_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0000000000004988","article-title":"Long-term relugolix combination therapy for symptomatic uterine leiomyomas","volume":"140","author":"Al-Hendy","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib21","article-title":"Advancing the inclusion of underrepresented women in clinical research","volume":"3","author":"Bierer","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajog.2023.10.030_bib22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.08.037","article-title":"Racial diversity in uterine leiomyoma clinical studies","volume":"94","author":"Taran","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.030_bib23","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jval.2022.06.005","article-title":"Development of the bleeding and pelvic discomfort scale for use in women with heavy menstrual bleeding associated with uterine fibroids","volume":"25","author":"Hudgens","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.ajog.2023.10.030_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate \u2606","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.030_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/AOG.0000000000003869","article-title":"Elagolix treatment for up to 12 months in women with heavy menstrual bleeding and uterine leiomyomas","volume":"135","author":"Simon","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib26","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1016\/j.fertnstert.2020.09.016","article-title":"Efficacy and safety of linzagolix (LGX) for the treatment of heavy menstrual bleeding (HMB) due to uterine fibroids (UF): results from two phase 2 randomized clinical trials","volume":"114","author":"Stewart","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.030_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/AOG.0000000000002990","article-title":"Examining disparities in route of surgery and postoperative complications in Black race and hysterectomy","volume":"133","author":"Alexander","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib28","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.ajog.2011.07.008","article-title":"Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends","volume":"205","author":"Wechter","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.030_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.fertnstert.2012.10.039","article-title":"Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy","volume":"99","author":"Moorman","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.10.030_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2012.3733","article-title":"Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials","volume":"21","author":"Coakley","year":"2012","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2023.10.030_bib31","doi-asserted-by":"crossref","first-page":"72.e1","DOI":"10.1016\/j.ajog.2020.07.032","article-title":"Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding\u00a0associated with uterine fibroids","volume":"224","author":"Al-Hendy","year":"2021","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:38:03Z","timestamp":1762079883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823007603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0002937823007603"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relugolix combination therapy in Black\/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}